Table of Contents

company-logo

Pharmicell Co., Ltd., a biopharmaceutical company, develops and sells stem cell drugs in South Korea and internationally. The company operates in Biopharmaceutical Business and Biochemical Business divisions. It offers Cellgram_AMI that is manufactured using autologous bone marrow-derived mesenchymal stem cell to enhance the ejection fraction in patients with acute myocardial infarction reperfused by coronary angioplasty. The company's products under development include Cellgram_LC, a liver disease drug; Cellgram_ED for treating impotence; and Cellgram_DC, a cancer drug, as well as Hearticellgram_AM, a cardiac disease drug. It also develops and produces intermediates of raw material medicines, such as nucleosides, mPEGs, HDP-tosylate, and vincelactam; and low dielectric constant material, eco-friendly flame retardant, polyol synthesis catalyst, PET catalyst, etc. In addition, the company operates Twelve, a stem cell bank; develops and sells stem cell culture media cosmetics. Pharmicell Co., Ltd. was founded in 2002 and is headquartered in Seoul, South Korea.

Pharmicell Dividend Announcement

• Pharmicell does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Pharmicell dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Pharmicell Dividend History

Pharmicell Dividend Yield

Pharmicell current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Pharmicell stock? Use our calculator to estimate your expected dividend yield:

Pharmicell Financial Ratios

P/E ratio102.24
PEG ratio3.14
P/B ratio4.22
ROE4.21%
Payout ratio0.00%
Current ratio9.01
Quick ratio4.44
Cash Ratio2.28

Pharmicell Dividend FAQ

Does Pharmicell stock pay dividends?
Pharmicell does not currently pay dividends to its shareholders.
Has Pharmicell ever paid a dividend?
No, Pharmicell has no a history of paying dividends to its shareholders. Pharmicell is not known for its dividend payments.
Why doesn't Pharmicell pay dividends?
There are several potential reasons why Pharmicell would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Pharmicell ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Pharmicell has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Pharmicell a dividend aristocrat?
Pharmicell is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Pharmicell a dividend king?
Pharmicell is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Pharmicell a dividend stock?
No, Pharmicell is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Pharmicell stocks?
To buy Pharmicell you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Pharmicell stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.